ÂÜÀòÂÒÂ×

Thomas Scullion PhD is an accomplished professional in the life sciences sector, currently serving as the Head of Business Development and Strategic Alliances at Synexa Life Sciences since September 2020. With extensive prior experience in business development roles, including leadership positions at Crown Bioscience, Inc. and Symbiosis Pharmaceutical Services Limited, Thomas has specialized in the Cardiovascular and Metabolic Disease market, drug discovery, and clinical services. Thomas's academic background includes a PhD in Neuropharmacology from Glasgow Caledonian University, complemented by a BSc (Hons) in Pharmacology, and foundational studies in Biology at the University of Aberdeen.